Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre

International Wound Journal

Volumn 9, Issue 4, 2012, Pages 403-411

  Shanmugam, Victoria K ^a   Schilling, Amber ^a   Germinario, Anthony ^a   Mete, Mihriye ^b   Kim, Paul ^a   Steinberg, John ^a   Attinger, Christopher E ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Bioengineered alternative tissue; Immune disease; Rheumatoid arthritis; Split thickness skin graft; Systemic lupus erythematosus

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BIOENGINEERED ALTERNATIVE TISSUE GRAFT; CHRONIC WOUND; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOLOGY; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; SKIN GRAFT; SPLIT THICKNESS SKIN GRAFT; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COHORT STUDIES; DATABASES, FACTUAL; DEBRIDEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOCOMPROMISED HOST; LEG ULCER; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SKIN TRANSPLANTATION; TERTIARY HEALTHCARE; TREATMENT OUTCOME; WOUND HEALING;

EID: 84863871649     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00899.x     Document Type: Article

References (51)

1. Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009;17:763-71.
2. Escandon J, Vivas AC, Tang J, Rowland KJ, Kirsner RS. High mortality in patients with chronic wounds. Wound Repair Regen 2011;19:526-8.
3. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007;25:9-18.
4. Broughton GI, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg 2006; 117:12S-34S. doi:10.1097/01.prs.0000225430.42531.c2.
5. Mack JA, Abramson SR, Ben Y, Coffin JC, Rothrock JK, Maytin EV. Hoxb13 knockout adult skin exhibits high levels of hyaluronan and enhanced wound healing. FASEB J 2003;17: 1352-4.
6. Mack JA, Maytin EV. Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice. J Invest Dermatol 2009;130:856-65.
7. Shanmugam VK, Price P, Attinger CE, Steen VD. Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol 2010;pii:747946. Epub 2010 Aug 18.
8. Tuffaneilli DL, Dubois EL. Cutaneous manifestations of systemic lupus erythematosus. Arch Dermatol 1964;90:377-86.
9. Shanmugam V, DeMaria D, Attinger C. Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression. Clin Rheumatol 2011;30:849-53.
10. Goslen JB. Autoimmune ulceration of the leg. Clin Dermatol 1990;8:92-117.
11. Gottrup F, Holstein P, Jorgensen B, Lohmann M, Karlsmar T. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg 2001;136:765-72.
12. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg Curr Conc Wound Heal 2006;117:72S-109S.
13. Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg 2011;127:75S-90S. doi:10.1097/PRS.0b013e3182009d9f.
14. Cuono C, Langdon R, McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1986;327:1123-4.
15. Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, Zawacki B. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg 1988;208:313-20.
16. Martin LK, Kirsner RS. Ulcers caused by bullous morphea treated with tissue-engineered skin. Int J Dermatol 2003;42:402-4.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
19. Fox R, Robinson C, Curd J, Kozin F, Howell F. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
20. Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr. The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary. Arthritis Rheum 1990;33:1135-6.
21. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr., Masi AT. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33:1065-7.
22. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28:1573-6.
23. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DeGroot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
24. Maessen-Visch MB, Koedam MI, Hamulyak K, Neumann HAM. Atrophie blanche. Int J Dermatol 1999;38:161-72.
25. Hairston BR, Davis M, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006;142:1413-8.
26. Callen JP. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol 2006;142:1481-2.
27. Shornick JK, Nicholes BK, Bergstresser PR, Gilliam JN. Idiopathic atrophie blanche. J Am Acad Dermatol 1983;8:792-8.
28. Gray HR, Graham JH, Johnson W, Burgoon CF. Atrophie blanche: periodic painful ulcers of lower extremities. A clinical and histopathological entity. Arch Dermatol 1966;93:187-93.
29. Shanmugam V, Steen V, Cupps T. Lower extremity ulcers in connective tissue disease [Review]. Isr Med Assoc J 2008;10:534-6.
30. Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and therapy of atrophie blanche. Arch Dermatol 1983;119:963-9.
31. Mimouni D, Ng PP, Rencic A, Nikolskaia OV, Bernstein BD, Nousari HC. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 2003;148:789-94.
32. Winkelmann R, Schroeter A, Kierland R, Ryan T. Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc 1974;49: 746-50.
33. Pun YL, Barraclough DR, Muirden KD. Leg ulcers in rheumatoid arthritis. Med J Aust 1990;153: 585-7.
34. Thurtle O, Cawley M. The frequency of leg ulceration in rheumatoid arthritis: a survey. J Rheumatol 1983;10:507-9.
35. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 2008;58:15-25.
36. Spector T. Rheumatoid arthritis. Rheum Dis Clin North Am 1990;16:513-37.
37. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007;56:2092-4.
38. Ward MM. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health 2005; 13:713-8.
39. Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48: 2246-55.
40. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008;58:26-35.
41. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, Hashimoto H, Nunoi H. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology 2011.
42. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50.
43. Madland TM, Apalset EM, Johannessen AE, Rossebö B, Prevalence JGB. disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005;32:1918-22.
44. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-9.
45. Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon 2009; 55:649-60.
46. Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol 2004;24:17-20.
47. Simpson S, Pittas F, van der Mei I, Blizzard L, Ponsonby A-L, Taylor B. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol, Neurosurg Psychiatry 2011;82:180-7.
48. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol, Neurosurg Psychiatry 2011;82:132-41.
49. Hafner J, Schneider E, Burg G, Cassina PC. Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg 2001;32:322-9.
50. Wood M, Davies D. Use of split-skin grafting in the treatment of chronic leg ulcers. Ann R Coll Surg Engl 1995;77:222-3.
51. Hafner J, Kohler A, Enzler M, Brunner U. Successful treatment of an extended leg ulcer in systemic sclerosis. VASA 1997;26:302-4.